Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Incannex Healthcare Inc.IXHL · Entity 7349 | CFO, Treasurer and Secretary | November 14, 2025 | November 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Incannex Healthcare Inc.
Report date November 14, 2025 · Filed November 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 921,358 |
Reported balance
After 2025-11-14 transaction · row 1
1 source rowRow 1 · 2025-11-14 · Grant · Acquired 869,565 · Balance 921,358 F1: Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 289,855 Shares that vest on December 10, 2025, (ii) 289,855 Shares that vest on June 30, 2026; and (iii) 289,855 Shares that vest on June 30, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 289,855 Shares that vest on December 10, 2025, (ii) 289,855 Shares that vest on June 30, 2026; and (iii) 289,855 Shares that vest on June 30, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2025 Filed Nov 14, 2025 06:14 UTC | Incannex Healthcare Inc. IXHL · Entity 7349 | GrantCommon Stock, $0.0001 par value per share | 869,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-110279 · ownership.xml · nonDerivative · entry 1 Swan Joseph · CIK 0002002769 · CFO, Treasurer and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 921,358 F1 · shares: Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 289,855 Shares that vest on December 10, 2025, (ii) 289,855 Shares that vest on June 30, 2026; and (iii) 289,855 Shares that vest on June 30, 2027. Read SEC document |
| May 06, 2024 Filed Aug 2, 2024 06:10 UTC | Incannex Healthcare Inc. IXHL · Entity 7349 | GrantRestricted Shares of Common Stock | 50,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-064333 · ownership.xml · nonDerivative · entry 1 Swan Joseph · CIK 0002002769 · CFO, Treasurer and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,793 F1 · date: Award of restricted shares of which 16,931 restricted shares vested on June 30, 2024, 16,931 restricted shares will vest on June 30, 2025, and 16,931 restricted shares will vest on June 30, 2026, provided the Reporting Person is still employed on each vesting date. F2 · kind: This Form 5 reports the award of 50,793 restricted shares by the Reporting Person pursuant to the Company's Equity Incentive Plan occurred on May 6, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.